AstraZeneca Can't Shed FCA Suit Over Seroquel 'Scheme'
A New York federal judge on Monday preserved a whistleblower's False Claims Act suit accusing AstraZeneca PLC of concealing safety information about antipsychotic drug Seroquel, finding plausible allegations of a "complex...To view the full article, register now.
Already a subscriber? Click here to view full article